全文获取类型
收费全文 | 693篇 |
免费 | 34篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 40篇 |
妇产科学 | 2篇 |
基础医学 | 79篇 |
口腔科学 | 17篇 |
临床医学 | 74篇 |
内科学 | 147篇 |
皮肤病学 | 21篇 |
神经病学 | 38篇 |
特种医学 | 123篇 |
外科学 | 73篇 |
综合类 | 12篇 |
预防医学 | 41篇 |
眼科学 | 2篇 |
药学 | 39篇 |
肿瘤学 | 37篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 20篇 |
2020年 | 5篇 |
2019年 | 6篇 |
2018年 | 7篇 |
2017年 | 13篇 |
2016年 | 14篇 |
2015年 | 15篇 |
2014年 | 19篇 |
2013年 | 25篇 |
2012年 | 12篇 |
2011年 | 16篇 |
2010年 | 33篇 |
2009年 | 40篇 |
2008年 | 19篇 |
2007年 | 35篇 |
2006年 | 24篇 |
2005年 | 15篇 |
2004年 | 23篇 |
2003年 | 7篇 |
2002年 | 12篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 9篇 |
1998年 | 36篇 |
1997年 | 37篇 |
1996年 | 30篇 |
1995年 | 29篇 |
1994年 | 11篇 |
1993年 | 19篇 |
1992年 | 3篇 |
1991年 | 7篇 |
1990年 | 16篇 |
1989年 | 15篇 |
1988年 | 20篇 |
1987年 | 17篇 |
1986年 | 12篇 |
1985年 | 14篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 13篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1972年 | 3篇 |
1968年 | 2篇 |
排序方式: 共有749条查询结果,搜索用时 0 毫秒
1.
Stuttering and tetanic syndrome 总被引:1,自引:0,他引:1
2.
3.
4.
5.
Inflammatory biomarkers in blood of patients with acute brain ischemia 总被引:11,自引:0,他引:11
S. Sotgiu B. Zanda B. Marchetti M. L. Fois G. Arru G. M. Pes F. S. Salaris A. Arru A. Pirisi G. Rosati 《European journal of neurology》2006,13(5):505-513
Although many failed surrogate markers are provided in the literature, inflammation may contribute to the outcome of ischemic stroke. In 50 consecutive patients with acute ischemic stroke, in the absence of symptoms and signs of concomitant infection, we evaluated a panel of biomarkers reported to be variably associated with brain ischemia, and correlate their serum level with the brain lesion volume and clinical outcome. Infarct size was calculated on computed tomography (CT) scans by means of the Cavalieri's method. Neurological impairment was scored by using the Glasgow Coma Scale, Glasgow Outcome Scale and National Institutes of Health (NIH) scales at stroke onset and 3-month follow-up. Some markers showed a direct significant correlation with both initial and final NIH scale and with infarct size, particularly tumor necrosis factor alpha (TNF-alpha) (P=0.002), intercellular adhesion molecule-1 (P<0.01) and matrix metalloproteinase-2/9 (P=0.001). In contrast to previous reports, interleukin-6 (IL-6) serum level showed a significant inverse correlation with both final neurological impairment and infarct size (P<0.001). This novel finding allows us suggesting that IL-6, in the context of a complex pro-inflammatory network occurring during stroke, is associated with neuroprotection rather than neurotoxicity in patients with ischemic brain injury. 相似文献
6.
Polycystic kidney disease is an autosomal dominant disease that may be associated with cystic disease of the liver. In women, the cysts may develop early and be more troublesome than in men. Cystadenocarcinoma of the pancreas is uncommon, comprising 1% of primary pancreatic malignancies. This case report is the first to describe a familial association between polycystic kidney disease and cystadenocarcinoma of the pancreas and liver in the English medical literature. A patient with autosomal dominant polycystic kidney disease (ADPKD) and multiple hepatic cysts developed cystadenocarcinoma of the pancreas with multiple malignant liver cysts. The patient's mother, sister, and niece had ADPKD, and the patient's sister also died of pancreatic cystadenocarcinoma. We believe that the development of these two disease entities in which the primary pathology is cyst formation has a genetic association. (Gastroenterology 1997 Jun;112(6):2104-7) 相似文献
7.
8.
9.
Annika?E?StenbergEmail author Lisskulla?Sylvén Carl?GM?Magnusson Malou?Hultcrantz 《Journal of negative results in biomedicine》2004,3(1):6
Disturbances in the immune system has been described in Turner syndrome, with an association to low levels of IgG and IgM
and decreased levels of T- and B-lymphocytes. Also different autoimmune diseases have been connected to Turner syndrome (45,
X), thyroiditis being the most common. 相似文献
10.
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy 总被引:3,自引:4,他引:3
Milasin J; Muntoni F; Severini GM; Bartoloni L; Vatta M; Krajinovic M; Mateddu A; Angelini C; Camerini F; Falaschi A; Mestroni L; Giacca M 《Human molecular genetics》1996,5(1):73-79
X-linked dilated cardiomyopathy (XLDC) is a familial heart disease
presenting in young males as a rapidly progressive congestive heart
failure, without clinical signs of skeletal myopathy. This condition has
recently been linked to the dystrophin gene in some families and deletions
encompassing the genomic region coding for the first muscle exon have been
detected. In order to identify the defect responsible for this disease at
the molecular level and to understand the reasons for the selective heart
involvement, a family with a severe form of XLDC was studied. In the
affected members, no deletions of the dystrophin gene were observed.
Analysis of the muscle promoter, first exon and intron regions revealed the
presence of a single point mutation at the first exon-intron boundary,
inactivating the universally conserved 5' splice site consensus sequence of
the first intron. This mutation introduced a new restriction site for MseI,
which cosegregates with the disease in the analyzed family. Expression of
the major dystrophin mRNA isoforms (from the muscle-, brain- and Purkinje
cell-promoters) was completely abolished in the myocardium, while the
brain- and Purkinje cell- (but not the muscle-) isoforms were detectable in
the skeletal muscle. Immunocytochemical studies with anti- dystrophin
antibodies showed that the protein was reduced in quantity but normally
distributed in the skeletal muscle, while it was undetectable in the
cardiac muscle. These findings indicate that expression of the muscle
dystrophin isoform is critical for myocardial function and suggest that
selective heart involvement in dystrophin- linked dilated cardiomyopathy is
related to the absence, in the heart, of a compensatory expression of
dystrophin from alternative promoters.
相似文献